The Valley Desk

NCT07282847 · Interventional trial

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions LOPD, Pompe Disease (Late-onset), Pompe Disease Late-Onset

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov